Artificial intelligence and radiomics biomarkers for treatment response prediction in advanced HER2-negative breast cancer.

Breast · 2025 · PMC12481087 · PMID 40974664

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

approached significanceno p-value reported

Notably, differences in baseline Component 4 values between the two groups approached significance, with a p-value of 0.055.

also in 8,237 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.